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The control of stem cell differentiation to obtain osteoblasts in vivo is still regarded as a challenge in stem-cell-based and bone-tissue
engineering strategies. Biodegradable dexamethasone-loaded dendron-like nanoparticles (NPs) of carboxymethylchitosan/poly(amidoamine)
dendrimer have been proposed as intracellular drug-delivery systems of bioactive molecules. In this study, combination of nanotechnology,
stem-cell engineering and tissue engineering is proposed in pre-programming the fate of rat bone marrow stromal cells (RBMSCs) towards
osteoblasts cells and development of new bone tissue, in vivo. This work demonstrated that the developed NPs were able to be taken up by
RBMSCs, and exhibited a noncytotoxic behavior in vitro. The performance of the developed dendronlike NP system for the intracellular
delivery of dexamethasone was investigated by seeding the engineered RBMSCs onto starch-polycaprolactone scaffolds ex vivo, and
implanting subcutaneously in the back of Fischer 344/N rats (Syngeneic), in the absence of the typical osteogenic supplements.
Favorable results were observed in vivo, thus suggesting that stem cell “tune-up” strategy can open up a new regenerative strategy for
bone-tissue engineering.
From the Clinical Editor: In this study, a combination of nanotechnology, stem-cell engineering and tissue engineering is proposed in pre-
programming the fate of rat bone marrow stromal cells (RBMSCs) towards osteoblasts cells and development of new bone tissue in vivo.
© 2011 Elsevier Inc. All rights reserved.
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NBM 2011;7:914-924, doi:10.1016/j.nano.2011.03.002development of novel strategies1-3 that can stimulate and control
cells' functions in vitro and in vivo. This issue is still regarded as a
very appealing challenge4-6 because there is the need to target-
deliver biological agents, including differentiation factors or
genetic material towards modulating from inside stem cells'
behavior.We find it interesting that You et al7 reported that surface
nanotopography of polyurethane polymer functionalized with
acrylate groups can enhance osteogenic differentiation synergis-
ticallywith biochemical induction substance in vitro. Nevertheless,
nanocarrier systems have generated a significant amount of interest
in ex vivo cell maintenance and co-culturing,8,9 and for tuning the
cellular fate in vivo mainly due to their internalization ability and
drug-loading capacity and to favorably modulate the solubility and
pharmacokinetics of drugs.10,11 Likewise, much attention has been
given12,13 to understanding the fundamental problem of the entry
and retention mechanisms of nanoparticles (NPs) on mammalian
cells as the nanodevices may be incorporated into membrane-noparticles for stem cells “tune-up”: from nano to tissues. Nanomedicine:
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this regard dendrimers have attracted growing interest as
nanocarriers due to their ability to cross cell membranes.14 Despite
the interesting architecture and multivalency, it has been found15
that high generation amine-terminated dendrimers are often
cytotoxic. Many researchers have proposed the designing of
dendrimers for biological and medical applications.16,17 Dendri-
mer-based NPs may be biocompatible, possess high loading
capacity and allow the bulk incorporation of bioactivemolecules of
higher molecular weights and of different chemistry while
maintaining internalization and transfection efficiencies in com-
parison with conventional dendrimers. Still, these have not been
successfully developed. We focused our attention on this
fundamental problem and propose a novel surface-engineering
strategy by using carboxymethylchitosan (CMCht), a natural
amphoteric polyelectrolyte derived from chitosan, grafted to a low
generation poly(amidoamine) dendrimer (PAMAM) backbone,
with the aim of obtaining copolymers of new architectures and
physicochemical properties,18 the so-called CMCht/PAMAM
dendrimer NPs. This class of nanobiomaterials has been projected
to act intracellularly towards tuning in vivo the stem cells' fate.
However, this remains ‘proof-of-concept’ with a previous report18
showing that the surface engineering of PAMAM dendrimer NPs
with the biodegradable CMCht possibly to manipulate the
chemical composition and improve biocompatibility, thus avoid-
ing the cytotoxic effects of high-generation dendrimers. Moreover,
upon loading of dexamethasone (Dex), the dendrimer nanocarriers
promoted the osteogenic differentiation of rat bonemarrow stromal
cells (RBMSCs) in vitro.18,19 The delivery of Dex by means of
using the NPs possibly a intracellular and regimented supply to
stem cells within the required range of concentrations, which can
be advantageous for proper osteogenic differentiation.
Here, we report on the effect of Dex-loading on the
architecture, zeta potential and internalization ability of the
developed NPs by RBMSCs. Transmission electron microscope
(TEM), dynamic light scattering (DLS) and fluorescence
techniques were carried out. To further investigate their
osteogenic potential, in vitro and in vivo studies were performed
combining cell and tissue engineering principles, i.e., using
natural nano- and micro-polymeric systems. In vitro minerali-
zation was evaluated by measuring the levels of calcein uptake.
For the in vivo studies, Dex-loaded CMCht/PAMAM dendrimer
NPs were exposed from culture media to RBMSCs during the
expansion period and seeded onto the surface of starch-
polycaprolactone (SPCL) scaffolds, followed by subcutaneous
implantation in the back of Fischer 344 (F344/N) rats for 4
weeks. Bone formation was evaluated by microcomputed
tomography (micro-CT) and morphometric analyses and histo-
logical studies (Haematoxylin & Eosin staining). Biochemical
analyses denoting osteogenesis such as ALP activity, osteocalcin
content and calcium assay were also carried out.Methods
Synthesis and characterization of the NPs
Synthesis of CMCht/PAMAM dendrimer NPs was performed
in a stepwise manner as described elsewhere.18 CMCht with adegree of deacetilation of 80% and degree of substitution of 47%
was linked to poly(amidoamine) dendrimers with an ethylene-
diamine core. First, the amine-terminated poly(amidoamine)
dendrimers (PAMAM-AT) was obtained from commercial
Starburst carboxylic-terminated poly(amidoamine) dendrimer
(PAMAM-CT, G1.5) (Aldrich, St. Louis, Missouri), as follows:
(1) an appropriate volume of PAMAM-CT was dissolved in
ultrapure water to give a final concentration of 10 mg.ml-1, and
the pH of the solution adjusted to 6.5 with dilute hydrochloride
acid (HCl) (Riedel de-Haen, Seelze, Germany), (2) 1-ethyl-3(3-
dimethylaminopropyl) carbodiimide hydrochloride, EDC
(Fluka, Buchs, Switzerland) was added to the PAMAM-CT
solution at a molar ratio sufficient to modify the carboxylate
residue of the dendrimers under agitation, (3) ethylenediamine
(EDA) (Sigma, Steinheim, Germany) was added to the solution
at a molar ratio equal to that of EDC, and (4) PAMAM-AT was
produced by removing excess of EDC by dialysis using a dialysis
tubing benzoylated (Sigma, Steinheim, Germany). Then, a
PAMAM-ester terminated dendrimer was obtained from
PAMAM-AT compound by adding an appropriate volume of
PAMAM-AT (∼ 8.4 mmol) and 1.14 ml of methyl methacrylate
(∼12.6 mmol) (Fluka) in methanol (Sigma) under agitation. The
PAMAM-ester terminated compound was obtained by precipi-
tation after 24 hours of reaction at 40°C. At last, CMCht/
PAMAM dendrimer was obtained by removing the acetal to
PAMAM-ester terminated compound20 and by adding the
CMCht at a ratio of 1:2 (w:w). The final solution was diluted
by adding 30 ml of methanol and kept under agitation for 1 hour.
After that time period, Dex-loaded CMCht/PAMAM dendrimer
NPs were obtained via a precipitation route by mixing the
CMCht/PAMAM dendrimer NPs with Dex at a final concentra-
tion of 5 × 10-5 M under agitation. NPs were obtained after
precipitation by adding an appropriate volume of a saturated
sodium carbonate, Na2CO3 (Aldrich) solution and cold acetone
(Pronalab, Lisbon, Portugal). The precipitate was collected by
filtration and dispersed in ultrapure water. The solution was
dialyzed against deionized water for several days by means of
using a dialysis tubing benzoylated (Sigma, St. Louis, Missouri).
The NP powders were obtained after freezing the solution at
−80°C and freeze-drying (Telstar-Cryodos -80, Terrassa, Spain)
up to 4 days to completely remove the solvent. Fluorescent probe
NPs were also synthesized using fluorescein isothiocyanate
(FITC).18 The incorporation of Dex into the CMCht/PAMAM
dendrimer NPs was investigated by 1H NMR spectroscopy.
CMCht/PAMAM dendrimer NPs and Dex-loaded CMCht/
PAMAM dendrimer NPs were dissolved in deuterated water,
D2O (Aldrich). The NMR spectra were obtained with a Mercury
- 400BB operating at a frequency of 399.9 MHz at 50°C. The
one-dimensional 1H NMR spectra were acquired using a 45°
pulse, a spectral width of 6.3 kHz and an acquisition time of
2.001 seconds. The changes on the morphology of the CMCht/
PAMAM dendrimer NPs after incorporation of Dex
was investigated under TEM (Philips CM-12, FEI Company,
Eindhoven, The Netherlands) equipped with a MEGA VIEW-II
DOCU camera and Image Software Analyzer SIS NT DOCU, as
previously described elsewhere.18 In addition, zeta potential and
particle-size distribution of the NPs loaded and nonloaded with
Dex were investigated at physiological and lysosomal typical
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Instruments, Worcestershire, United Kingdom). For this study,
particle-size analyses were also performed by DLS in an aqueous
solution with low concentration of NPs and using disposable
sizing cuvettes. Electrophoretic determinations of zeta potential
were investigated in citrate buffer (pH 3) and phosphate buffered
saline (PBS) of pH 7.4 solutions, using the universal ‘dip’ cell.
Zeta potential was also investigated in water. For further details
see Supplementary Information.
SPCL scaffolds
A blend of starch and poly-ɛ-caprolactone from Novamont
(Novara, Italy) 30/70 (w/w) was used to produce fibers of SPCL
bymelt spinning using amodular co-rotating twin screw extruder.
SPCL scaffolds with 5 mm diameter and 4 mm height were
obtained by fiber bonding as reported elsewhere.19,21 Before in
vitro and in vivo studies, the CMCht/PAMAM dendrimer NPs,
the Dex-loaded CMCht/PAMAM dendrimer NPs and SPCL
scaffolds were sterilized in an ethylene-oxide gas atmosphere.
Cells isolation and luminescent cell viability assay
(ATP quantification)
For the in vitro cell culturing studies, RBMSCs were isolated
from femora of 7-week-old male Fischer 344/N rats (SLC Inc.,
Hammamatsu, Japan), and expanded in T75 cm2 culture flasks in
the presence of Eagle's minimum essential medium (MEM)
(Nacalai Tesque, Kyoto, Japan) supplemented with 15% fetal
bovine serum (FBS), (JRH Biosciences, Tokyo, Japan) and 1%
antibiotic/antimycotic (A/B) (Nacalai Tesque) solution, the so-
called MEM complete medium. First, the animals were sacrificed
following the protocol approved byEthics Committee at the Tissue
EngineeringResearchCenter, Amagasaki, Japan. The femorawere
collected, themarrow flushed out andmarrow cells from each shaft
were transferred into a T75 cm2 culture flask (BD Biosciences
Discovery Labware, Bedford, Massachusetts) and expanded under
standard culturing conditions. The culture medium was changed
within a 3-day period to remove nonadherent cells, followed by
changing the culturemedium every 2 or 3 days until reaching about
80% confluence. RBMSCs were trypsinized with 1 ml of 0.05%
tripsin-0.53 mM EDTA (Invitrogen, Carlsbad, California) solu-
tion, and incubated for 3 minutes at 37°C. Complete MEM culture
mediumwas added and RBMSCs (passage 1, P1) were centrifuged
at 900 rpm for 5minutes. Then, supernatant was aspirated and cells
resuspendedwith 10ml of complete culturemedium.Cell counting
was performed using an automated counter (Cell Counter Sysmex
F-520, Kobe, Japan). Viability of RBMSCs was analyzed with a
NucleoCounter (Chemometec, Allerød, Denmark), prior seeding.
To investigate possible cytotoxicity of the NPs, a cell-
viability assay was carried out. RBMSCs were seeded
(subcultured) to each well of a 96-well tissue culture polystyrene
(TCPS) plate at a cell density of 5 × 103 cells.ml-1. Serial
dilutions (1, 0.1, 0.01 mg.ml-1) of CMCht/PAMAM dendrimer
NPs and Dex-loaded CMCht/PAMAM dendrimer NPs were
prepared using the MEM complete culture medium, and
RBMSCs cultured with the respective media for 24 and 72
hours. A latex rubber extract was used as the positive control for
cellular death. After each time point, the ATP content wasmeasured by means of performing a CellTiter-Glo luminescent
cell-viability assay (Promega Corp., Madison, Wisconsin).
Luminescence was measured in a microplate reader (Wallac
ARVOsx 1420, Perkin-Elmer Life and Analytical Sciences,
Shelton, Connecticut). All experiments were carried out in
triplicate using 4 replicates per experimental condition (n=12).
In vitro cellular uptake ability of the dendronlike NPs
RBMSCs were isolated and expanded as aforementioned.
Then, cells were subcultured in a 6-well (1 × 105 cells.well-1) and
TCPS coverslips in 24-well TCPS plates (2 × 104 cells.well-1) for
analysis under FACS and fluorescence microscopy, respectively.
For fluorescence microscopy, RBMSCs were cultured in a
MEM complete culture medium supplemented with the FITC-
labelled Dex-loaded CMCht/PAMAM dendrimer NPs and
MEM complete culture medium with the FITC-labelled
CMCht/PAMAM dendrimer NPs at a final concentration of
0.1 mg.ml-1, for the period of 12 hours for 14 days. For FACS
analysis, RBMSCs were cultured in the presence of FITC-
labelled Dex-loaded CMCht/PAMAM dendrimer NPs and
FITC-labelled CMCht/PAMAM dendrimer NPs at a final
concentration of 0.01 mg.ml-1. All experiments were carried
out in triplicate. After each time period, the RBMSCs were fixed
with 4% formalin (Nacalai Tesque) and incubated with Texas
Red-X phalloidin (Molecular Probes, Invitrogen) and Hoechst
33258 (Invitrogen) for staining the actin filaments of cytoskel-
eton and nuclei of cells, respectively. We followed the protocols
provided by the supplier, with few modifications. The specimens
were observed under a fluorescence microscope (Olympus IX70,
Olympus Co. Ltd., Tokyo, Japan).
Before FACS analysis each well of the 6-well plate was
washed with PBS and cells released from substratum as described
above. After centrifugation at 900 rpm for 5 minutes, RBMSCs
were resuspended in 0.5 ml of complete culture medium and
passed through cell strainers.22 Propidium iodide (Nacalai
Tesque) was added to each sample to determine the number of
live cells. Then, RBMSCs were loaded in a FACSCalibur flow
cytometer (BD Biosciences Immunocytometry Systems, San
Jose, California) and analyzed with a minimum of 10,000 events
counting. All experiments were carried out in triplicate and
following the protocol described elsewhere.18
In vitro assessment of osteogenesis and viability assay
RBMSCs (P1) were cultured in a TCPS 24-well plate at a cell
density of 2 × 104 cells.well-1 for 24 hours. After that time, the
culture medium was replaced by the different culture medium,
and RBMSCs cultured for up to 14 days. The effect of the
concentration of Dex-loaded CMCht/PAMAM dendrimer NPs
on the RBMSCs osteogenic differentiation was investigated as
previously reported elsewhere, using positive and negative
controls for osteogensesis.18 The degree of mineralization was
qualitatively and quantitatively investigated as described by
Uchimura et al.23 The method consists of the culturing of the
RBMSCs in the presence of 1 μg.ml-1 of calcein (Dojindo
Laboratories, Kumamoto, Japan), which is incorporated in the
mineralized ECM and allows us to investigate the calcium
deposition, after 1, 7 and 14 days. The fluorescence of calcein
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and quantified in a image analyzer equipment (Typhoon 8600
Variable Mode Imager, Amersham Biosciences, Piscataway,
New Jersey) using a 526 nm short pass filter. Afterward, the
fluorescence of the incorporated calcein was also observed under
a fluorescence microscope (Olympus IX70, Olympus Co., Ltd.).
All experiments were carried out 3 times using a minimum of 4
replicates per experimental condition (n=12).
In vivo study
RBMSCs were expanded in different culture media namely,
MEM, MEM supplemented with Dex and MEM supplemented
with the Dex-loaded CMCht/PAMAM dendrimer NPs.
RBMSCs at different cell number (1 × 106 and 2 × 105) were
seeded onto the surface of the SPCL scaffolds, cultured
overnight in MEM complete medium for cell adhesion, and
then constructs were implanted subcutaneously. Seven-week-old
male F344/N rats (Syngeneic), same as donor substrain and age,
were anesthetized by intraperitoneal injection of pentobarbital
(Nembutal, Dainippon Pharmaceutical Co. Ltd., Osaka, Japan) at
a final concentration of 3.5 mg per 100 g of body weight. In each
rat, 3 or 4 skin incisions (each 1 cm length) on the dorsal midline
below the ear were made. Each RBMSCs-SPCL constructs was
implanted subcutaneously (1.5 to 2 cm away from the midline at
both right and left sides) into the respective pocket and skin
sutured. As a negative control, we used SPCL implants without
RBMSCs. All animals received their usual dietary regimen and
no prophylactic medication was administered post surgery. After
4 weeks' implantation, the animals were sacrificed with an
overdose of anesthetic and the implants were retrieved. All
experiments were carried out 3 times using a minimum of 3
implants per condition.
Micro-CT and morphometric analysis
New bone formation in the explants was evaluated using a
high-resolution micro-CT Skyscan 1072 scanner (Skyscan,
Kontich, Belgium) with a resolution of pixel size of 6.59 μm
and integration time of 1.7 ms. The x-ray source was set at 40
keV and 250 μA. Approximately 400 projections were acquired
over a rotation range of 180° with a rotation step of 0.45°. Data
sets were reconstructed using standardized cone-beam recon-
struction software (NRecon v1.4.3, SkyScan). The output
format for each sample was 500 serial 1024 × 1024 bitmap
images. A representative data set of 250 slices was segmented
into binary images with a dynamic threshold of 220-255 (grey
values) to assess de novo bone formation. The same
representative volume of interest (VOI) was analysed for all
the samples. These data sets were used for morphometric
analysis (CT Analyser, v1.5.1.5, SkyScan) and to build the 3D
models (ANT 3D creator, v2.4, SkyScan). The morphometric
analysis included scaffold characterization such as porosity and
interconnectivity, histograms and new bone formation quanti-
fication. The distribution of this new bone formation in the
scaffolds was assessed by 3D virtual models that were created,
visualized and registered using both image-processing softwares
(CT Analyser and ANT 3D Creator). After μ-CT analysis the
explants were prepared as described in the SupplementaryInformation following a standard protocol24 for further
histological observation.
Histological analysis
After micro-CT analysis, the explants were decalcified with
K-CX solution (Falma Co., Tokyo, Japan) for histological
analysis. First, the explants were dehydrated in an ascending
series grade ethanol/water solution (from 90–100%) for 19 hours
followed by washing 3 times with xylene. Then, explants were
immersed in paraffin at 62°C and allowed to solidify at -5 °C.
Slides were prepared by cutting the explants into sections 5 μm
thick using a microtome and mounted in a microslide glass
(Matsunami Glass Ind. Ltd., Osaka, Japan). Paraffin was melt by
placing the slides in the oven at 71°C for 20 minutes and allowed
to let cool down at room temperature (18–21°C). The remnant
paraffin was then subsequently removed from slides by
immersion in hexane for 5 minutes (S.T. Chemical Co. Ltd.,
Tokyo, Japan), and in a ethylene/propylene mixture (Clear Plus,
Falma Co., Tokyo, Japan) for 3 minutes. Then, slides were
immersed 3 times in 100% ethanol for 2 minutes each time of
immersion. For the Haematoxylin & Eosin (H&E) staining,
slides were sequentially transferred to a 90% ethanol and then to
a 70% and washed with tap water. It followed the staining steps
and mounted for observation as described elsewhere.10 All
experiments were carried out in triplicate using 3 replicates per
experimental condition (n=9).
Analyses of biochemical parameters
ALP activity and osteocalcin content were measured to
evaluate osteoblast differentiation in vivo. Before the assay the
explants were washed with Ca and Mg-free PBS solution. Then,
explants were processed as previously reported.19,24 Standards
were prepared with p-nytrophenol, pNP. Triplicates were made
for each sample and standard and experiments repeated 3 times
(n=9). Absorbance was read at 405 nm (Wallac ARVOsx 1420,
Perkin-Elmer Life and Analytical Sciences), and sample
concentrations were read from the standard graph. Enzyme
activity was expressed either as nmol of pNP released/explant/30
minutes. The remnant of each sample used for the ALP assay of
the explants was treated with a 20% formic acid solution and
stored at 4°C for 2–3 days. Afterward samples were centrifuged
at 15,000 rpm and the supernatant was passed through a
Sephadex G-25 column (GE Healthcare, Uppsala, Sweden). The
samples were subsequently concentrated for performing the
enzyme-linked immunosorbent assay (ELISA). A rat osteocalcin
EIA kit (N° BT-460, Biomedical Technologies Inc., Stoughton,
Massachusetts) was used following the instructions provided by the
supplier. Data were read off from the standard curve obtained
with human osteocalcin and expressed as ng of deposited
osteocalcin per explant. As an index of mineral bone formation,
deposited calcium in the explants was quantified as described by
Kim et al25 with minor modifications. Statistical analysis was
carried out as described in the Supplementary Information.
For calcium determination, explants were rinsed with Ca and
Mg-free PBS solution and 0.2 ml of 1N HCl solution per explant
was added. The tissues were chopped before being placed on an
orbital shaker to extract calcium for 12 hours. Then, mixtures
Figure 1. Characterization of the nanoparticles. Representative TEM images of the CMCht/PAMAM dendrimer NPs (A), and Dex-loaded CMCht/PAMAM
dendrimer NPs (B).
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were assayed (o-cresolphthalein complexation color develop-
ment method) using a commercial calcium assay kit (Calcium C-
test, Wako Pure Chemical Industries, Osaka, Japan). Calcium
content was determined by measuring the absorbance at 570 nm.
All experiments were carried out in triplicate using 3 replicates
per experimental condition (n=9).
Statistical analysis
Statistical differences were analysed using the GraphPad
Prism software (GraphPad Software Inc., La Jolla, California).
One-way analysis of variance (Tukey's multiple comparison
test) was performed and statistical significance was defined as
P b 0.05 for a 95% confidence interval (P value: ⁎⁎⁎ b
0.001; ⁎⁎ b 0.01; ⁎ b 0.05).Results
In the present work, 1H NMR analysis was carried to
investigate the loading of Dex into the Dex-loaded CMCht/
PAMAM dendrimer NPs (Figure S1). The spectrum shows the
typical signals from CMCht, PAMAM dendrimers and Dex. It is
possible to observe small singlets at 1.14, 1.28 ppm and 1.86
ppm from CH3 and CH2 groups, and a doublet at 7.55 ppm and
7.96 ppm, which are attributed to the chemical shifts of the
protons attached to C1 atoms and to aromatic ring (⁎) of Dex,
respectively. By its turn, to evaluate the morphology of the NPs
upon loading with Dex, TEM analysis was performed (Figure 1).
From images we can observe that the loading of Dex can affect
the morphology of the NPs. In fact the formation of dendronlike
NPs instead of the typical nanosphere-like morphology is
revealed. Zeta potential and particle size of the CMCht/
PAMAM dendrimer NPs and Dex-loaded CMCht/PAMAM
dendrimer NPs were also measured by DLS (Table S1). Results
showed that the hydrodynamic diameter of the CMCht/PAMAM
dendrimer NPs in PBS (pH 7.4), increased upon Dex loading,and the value of the NPs' zeta potential changed from −32.8 to
−27.3 mV (experiments carried out in water).
In vitro cell culture studies were performed to investigate
possible cytotoxicity and uptake of NPs by RBMSCs. Fluores-
cence microscopy images of RBMSCs cultured in the presence
of FITC-labeled and Dex-loaded CMCht/PAMAM dendrimer
NPs revealed that the NPs are taken up by RBMSCs, after 12
hours (Figure 2). The cell-viability assay of RBMSCs cultured in
the presence of different culture medium revealed that NPs are
noncytotoxic over RBMSCs at concentrations bellow 1 mg.ml-1
(Figure S2). FACS analysis was also performed after culturing
the RBMSCs in the presence of the FITC-labelled NPs for up to
14 days (Figure S3 and Table S2). FACS analysis revealed
increasing levels of fluorescence associated with cells after
incubation of RBMSCs with CMCht/PAMAM dendrimer NPs.
The fraction of live cells cultured in the presence of FITC-labeled
Dex-loaded CMCht/PAMAM dendrimer NPs do not signifi-
cantly differ from that of controls. This is a good indication that
NPs do not elicit any cytotoxic effect over RBMSCs. The
osteogenic ability of Dex-loaded CMCht/PAMAM dendrimer
NPs was investigated by qualitatively and quantitatively
determining the levels of calcein uptake (Figure 3 and Figure
S4). Results demonstrated that mineralization can only occur in
cultures in which RBMSCs were supplemented with Dex-loaded
CMCht/PAMAM dendrimer NPs in comparison with to positive
control (osteogenic medium). Moreover, it can be seen that NP
concentration significantly affects mineralization, i.e., superior
mineralization occurs when using 0.01 mg.ml-1 Dex-loaded
CMCht/PAMAM dendrimer NPs in comparison with that for
1 mg.ml-1 Dex-loaded CMCht/PAMAM dendrimer NPs. The
osteogenic studies are supported by phase contrast and respective
fluorescence microscopy images of RBMSCs after culturing
in different culture medium and in the presence of calcein for
14 days (Figure S5). In the Figures 5S, C-E, it can be observed
the typical mineral nodule formation in RBMSCs cultures that
were exposed to Dex, both from culture media or from the
Dex-loaded CMCht/PAMAM dendrimer NPs.
Figure 2. Cellular uptake of the dendronlike NPs. Fluorescence microscopy images of the RBMSCs cultured in the presence of FITC-labelled Dex-loaded
CMCht/PAMAM dendrimer NPs 0.1 mg.ml-1 (green) for: 12 h (A) 24 h (B) 7 d (C) and 14 d (D). Nuclear DNA and cytoskeleton were labeled with Hoechst
33258 (blue) and Texas-red phalloidin (red), respectively.
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PAMAM dendrimer NPs in the production of new bone was
evaluated using RBMSCs seeded onto the SPCL scaffolds. The
effect of cell number on the bone-forming ability was investigated.
No signs of infection or acute inflammatory reaction were detected
at the implantation sites for all implants after 4 weeks of
implantation (Figure S6). Figure 4 shows the 3Dmicro-CT images
and respective H & E stained sections of the explants. Further 3D
micro-CT morphometric analysis can be seen in Supplementary
Information (Figures S7-S9). Moreover, ALP activity, osteocalcin
and calcium contents of the explants were also quantitatively
investigated. Results demonstrated that cell density and culture
conditions greatly affect in vivo bone formation. From data, it can
be seen that bone formation occurs when seeding the SPCL
scaffolds with 1 × 106 RBMSCs exposed to Dex either from
culture medium and Dex-loaded CMCht/PAMAM dendrimer NPs
during expansion ex vivo. The biochemical data corroborated
the histological and micro-CT findings. A significant increase
(P b 0.001) in the calcium deposited is observed culturing
RBMSCs with Dex-loaded CMCht/PAMAM dendrimer NPs in
comparison with explants seeded with 1 × 106 RBMSCs
exposed to Dex from culture medium.Discussion
The water-soluble NPs were characterized by NMR, DLS and
TEM. The 1H NMR spectra of CMCht/PAMAM dendrimer NPs
and Dex-loaded CMCht/PAMAM dendrimer NPs are provided
as Supplementary Information (Figure S1). The spectrum of the
Dex-loaded CMCht/PAMAM dendrimer NPs shows the typical
signals from CMCht, PAMAM dendrimers and Dex. It is
possible to observe the chemical shifts of the protons attached to
C1 atoms and to aromatic ring of Dex, which clearly shows that
Dex26 was effectively loaded into the CMCht/PAMAM
dendrimer NPs.24 This data corroborate previous findings,18
which showed that Dex can be loaded into the NPs and released
as free drug. The release kinetics of Dex follow a steady release
after the initial burst (24 hours), which can last for 7 days. In fact,
experiments performed in PBS with 15 % FBS,18 revealed that
Dex concentration reaches a plateau of 4 μg.ml-1. This data
revealed that by adding the Dex-loaded CMCht/PAMAM
dendrimer NPs to culture media at a final concentration of
0.01 mg.ml-1, the concentration of Dex is expected to be in the
magnitude of 10 nm. The time scale for the Dex release from the
NPs was observed to be in the same order of their internalization
Figure 3. In vitro osteogenic ability of the dendron-like NPs. Fluorescence
intensity values of RBMSCs cultured in the presence of calcein, for the
period of 1-14 days. Values were related to fluorescence intensity of
RBMSCs cultured in the absence of calcein, for each condition. (A) MEM
medium (negative control); (B) 1 mg.ml-1 CMCht/PAMAM dendrimer
NPs; (C) 1 mg.ml-1 Dex-loaded CMCht/PAMAM dendrimer NPs; (D)
0.01 mg.ml-1 Dex-loaded CMCht/PAMAM dendrimer NPs; (E) Osteo-
genic medium, and (F) MEM medium with β-glycerophosphate. Results
are expressed as mean ± s.d. (n = 12). The Tukey's multiple comparison
test was used for statistical analysis.
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PAMAM dendrimer NPs that exhibit a spherical shape. We can
also observe that the loading of Dex can affect the morphology of
the NPs (Figure 1, B). In fact, it is possible to observe the
formation dendron-like NPs, instead of the typical nanosphere-
like morphology. To investigate the effect of pH on the particle
size and distribution, and zeta potential DLS analysis were
performed. These studies were carried out at physiological and
lysosomal typical pH's (see Table S1). The results show that
upon loading of Dex into the CMCht/PAMAM dendrimer NPs,
the hydrodynamic diameter of the particles and polydispersivity
increased, and no significant changes on the zeta potential was
observed at pH 7.4. However, when the DLS studies were carried
out in water, the value of zeta potential of the NPs changed from
−32.8 to −27.3 mV, upon loading of Dex. In an acidic medium,
the amino and carboxylic groups of CMCht are protonated.
Thus, the zeta potential of the NPs at pH 3 loosed the strong
negative character, as expected. In fact at slightly acidic, the NPs
will possess a zero charge. This would mean that when
internalized by cells and inside the lysosomes (pH b 5.5), as
the NPs possess a significant buffering capacity, it can act as
“proton sponges”.27 Therefore, we can hypothesize that the
neutralization of the NPs' surface charge at acidic pH's can cause
coagulation of the particles and prevent Dex release within
lysosomes. Actually, the charge conversion may be beneficial for
lysosomal escape and subsequently release Dex in the cyto-
plasm, where it can bind and activate the glucocorticoid receptor.
This behavior may open other application possibilities namely,
the use of these nanocarriers in gene delivery. However, these
statements remain to be clarified and studies in these directions
will be reported elsewhere.As mentioned, particle size can affect internalization by cells.
On the other hand, in a report by Zhang et al28 it was
demonstrated that Dex treatment decreases the phagocytosis of
Staphylococcus aureus bioparticles, in normal primary trabec-
ular meshwork cells. To further investigate if the incorporation of
Dex into the NPs may affect the internalization ability of
RBMSCs, a FITC probe was linked to these NPs. Fluorescence
microscopy images of RBMSCs cultured in the presence of
FITC-labeled and Dex-loaded CMCht/PAMAM dendrimer NPs
revealed that the NPs are taken up by RBMSCs, after 12 hours
(Figure 2). RBMSCs continued to internalize the NPs (higher
fluorescent signals), when maintained for longer culturing
periods. These data are corroborated by the cell viability study
(see Figure S2), demonstrating the noncytotoxicity of Dex-
loaded CMCht/PAMAM dendrimer NPs. Fluorescence-activated
cell sorter (FACS) analysis was also performed after culturing
the RBMSCs in the presence of the FITC-labeled NPs for up to
14 days (Figure S3 and Table S2). FACS analysis revealed
increasing levels of fluorescence associated with cells after
incubation RBMSCs with CMCht/PAMAM dendrimer NPs. The
fraction of live cells cultured in the presence of FITC-labelled
Dex-loaded CMCht/PAMAM dendrimer NPs do not signifi-
cantly differ from that of controls. This is a good indication that
NPs do not elicit any cytotoxic effect over RBMSCs.
The later stages of the osteogenic differentiation of
mesenchymal stem cells give rise to cells able to produce
mineralized extracellular matrix (ECM). The osteogenic ability
of Dex-loaded CMCht/PAMAM dendrimer NPs was investi-
gated by qualitatively and quantitatively determining the levels
of calcein uptake. This method allows monitoring the calcein
fluorescence arising from the mineralization process,23 which
denotes the osteogenic activity in a culture (Figure S4). It is
possible to observe that mineralization can only occur in cultures
in which RBMSCs were supplemented with Dex-loaded CMCht/
PAMAM dendrimer NPs and osteogenic medium. Figure 3
shows the fluorescence intensity values of RBMSCs cultured in
the presence of calcein. These results revealed that no significant
differences in mineralization were observed for cultures
supplemented with 0.01 mg.ml-1 Dex-loaded CMCht/PAMAM
dendrimer NPs in comparison with that for osteogenic medium.
This is a good indication that the NPs possess osteogenic ability
within this range of concentrations. By its turn, the calcein
uptake, which denotes the degree of mineralization, is decreased
in cultures supplemented with Dex-loaded CMCht/PAMAM
dendrimer NPs at a concentration of 1 mg.ml-1. This data
indicates that the NPs' concentration is not the optimal level to
allow the supply of Dex within the optimal range of
concentrations to maximize the osteogenesis. These data are
not surprising, because it has been reported29,30 that optimal
concentration (10-8 M) and regimented supply of Dex is needed
for promoting the differentiation of RBMSCs towards osteoblast
over adipocytes. These results are supported by phase contrast
(left) and respective fluorescence microscopy images of
RBMSCs after culturing in different culture media and in the
presence of calcein for 14 days (see Figure S5).
In in vivo experiments (Figure 4), the ability of the Dex-
loaded CMCht/PAMAM dendrimer NPs toward the production
of new bone was evaluated using SPCL scaffolds with 67.4 ±
Figure 4. In vivo de novo bone formation ability of the dendronlike NPs. 3D micro-CT images and respective H & E stained sections of the explants. ALP
activity, osteocalcin and calcium contents of the explants after 4 weeks of subcutaneous implantation: SPCL scaffold explants (A) explants with 2 × 105
RBMSCs cultured in MEM (B) explants with 1 × 106 RBMSCs cultured in MEM (C) explants with 2 × 105 RBMSCs cultured in MEM with Dex (D) explants
with 1 × 106 RBMSCs cultured in MEMwith Dex (E) explants with 2 × 105 RBMSCs cultured in MEMwith Dex-loaded CMCht/PAMAM dendrimer NPs (F)
and explants with 1 × 106 RBMSCs cultured in MEM with Dex-loaded CMCht/PAMAM dendrimer NPs (G). Results are expressed as mean ± Standard
deviation (SD) (n = 9). The Tukey's multiple comparison test was used for statistical analysis (P value: ⁎⁎⁎ b 0.001; ⁎⁎ b 0.01; ⁎ b 0.05).
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These were chosen because we found previously19 that SPCL is
an adequate support for the RBMSCs osteogenic differentiationin vitro. The SPCL scaffolds also exhibits lower attenuation
coefficient than that for bone or calcium phosphates, i.e., the
intensity of the x-ray beam is reduced less as it passes through the
Figure 5. Schematic illustration of ex vivo stem cells “tune-up” and de novo bone tissue formation in vivo. Dendronlike NPs are internalized by stem cells in
vitro, and then cells are seeded onto SPCL scaffolds and implanted. Release of Dex to the cytoplasm will occur and de novo bone formation (blue areas) is
observed within SPCL scaffolds after 4 weeks of implantation.
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the total volume of newly formed bone into implants by using
this technique.31 We cultured in vitro the RBMSCs in the
presence of 0.01 mg.ml-1 Dex-loaded CMCht/PAMAM den-
drimer NPs until reaching confluence, seeded the RBMSCs onto
the surface of the SPCL scaffolds overnight followed by
subcutaneous implantation into the back of F344/N rats for 4
weeks. The effect of cell number on the bone-forming ability was
also investigated because we have reported that it may influence
de novo bone formation.24 No signs of infection or acute
inflammatory reaction were detected at the implantation sites for
all implants after 4 weeks of implantation (see Figure S6). From
micro-CT analyses of the explants namely, SPCL alone and
SPCL scaffolds seeded with 2 × 105 and 1 × 106 RBMSCs
(explants) whose cells were expanded in MEMmedium, no areas
of high attenuation were observed (Figure 4, A-C). On the
contrary, it was possible to observe regions of higher attenuation
between 0.7 and 0.8 cm-1 (black arrow) in the constructs seeded
with 1 × 106 RBMSCs that were exposed to Dex and Dex-loaded
CMCht/PAMAM dendrimer NPs (Figure 4, E and G; also see
Figure S7). The areas of higher attenuation detected can be an
indication of de novo bone formation because the SPCL
scaffolds and SPCL explants have an attenuation coefficient
between 0.3 and 0.6 cm-1, which is lower than that for ceramics
and mineralized matrices. To confirm such hypothesis, histo-
logical and biochemical studies were carried out. Figure 4 (top)
shows the 3D images of the SPCL scaffolds and explantsobtained from micro-CT analyses and respective microscopic
images of the explants histological sections stained with H & E.
By analyzing the images after imposing a threshold to evidence
the high-density regions, it is possible to observe that the region
of higher attenuation observed corresponds to the white area in
the 3D micro-CT images (see Figures S7-S8). In fact, compact
masses (white area) were only observed in the explants whose
RBMSCs were exposed to Dex and Dex-loaded CMCht/
PAMAM dendrimer NPs during expansion, in vitro (Figure 4,
E and G). No bone formation in the explants of SPCL alone
(control) and SPCL scaffolds seeded with 2 × 105 RBMSCs was
observed (Figure 4, A-B). From the histological photographs of
the explants, it became evident that the massive area of high
attenuation (white area) corresponds to newly formed bone. By
its turn, explants whose RBMSCs were not exposed to Dex,
fibrous tissue formation within the pores of SPCL scaffolds was
observed. The superior bone organization in the explants whose
RBMSCs were supplemented with Dex-loaded CMCht/
PAMAM dendrimer NPs in comparison with that whose
RBMSCs were supplemented with Dex from culture media
might be one of the most important achievements in this study.
Cuboid osteoblasts lining the forming bone matrix in SPCL
scaffolds seeded with 1 × 106 RBMSCs indicate an active bone
formation site (black arrow) (Figure 4, G). It is also possible to
observe the lacunar spaces and reminiscent osteocyte-like cells
entrapped in the bone matrix (white arrows). Thus, osteocytic
lacunae in the lamellar bone are uniform and regularly
923J.M. Oliveira et al / Nanomedicine: Nanotechnology, Biology, and Medicine 7 (2011) 914–924distributed with osteoblasts forming a continuous layer of bone
in a unidirectional way typical of mature bone. Moreover, we
observed that new bone formation occurs primarily at the middle
section of the scaffold (see Figure S8B), which reveals that the
scaffolds possess an adequate pore size and interconnectivity.
Micro-CT analyses also revealed that in the explants with 1 × 106
RBMSCs cultured in MEM media, bone formation occurs
though in low amounts. To evaluate further the osteogenic
differentiation in vivo, the alkaline phosphatase (ALP) activity
was measured (Figure 4, bottom left). Results demonstrated that
ALP activity significantly increased in the explants seeded with
1 × 106 RBMSCs that were exposed to Dex-loaded CMCht/
PAMAM dendrimer NPs as compared to either, explants seeded
with 2 × 105 RBMSCs exposed to Dex-loaded CMCht/PAMAM
dendrimer NPs and explants seeded with 1 × 106 RBMSCs
exposed to Dex supplemented from culture media. These data are
not surprising because the previous in vitro release study18 of
Dex from the CMCht/PAMAM dendrimer NPs showed that Dex
concentration resembles that from osteogenic media. This article,
however, reports for the first time that SPCL scaffolds are
effective in supporting the osteogenic differentiation of
RBMSCs and de novo bone formation in vivo. Figure 4 (bottom
center) shows the content of the late osteogenic marker and bone-
specific osteocalcin in the explants after 4 weeks of implantation.
No significant differences in osteocalcin levels were seen for
SPCL explants without cells and seeded with 2 × 105 RBMSCs
cultured in MEM and MEM supplemented with Dex. Although
there is an statistical increase (P b 0.05) in osteocalcin levels for
the explants seeded with 1 × 106 RBMSCs exposed to Dex-
loaded CMCht/PAMAM dendrimer NPs in comparison with that
of the explants seeded with 2 × 105 RBMSCs cultured in the
same culture conditions. Moreover, a significant increase of the
osteocalcin content can be observed in the explants seeded with
1 × 106 RBMSCs exposed to Dex in comparison with that of the
explants seeded with 2 × 105 RBMSCs. This data revealed that
cell number significantly affects this late osteogenic marker in
vivo. Significant differences in the organization of the newly
formed bone were observed under the histological studies. To
elucidate these findings, calcium was extracted from the explants
by acid treatment to investigate the quality and degree of
mineralization of the newly bone formed (Figure 4, bottom right).
No considerable calcium deposition was found in the explants of
SPCL scaffold and SPCL scaffolds seeded with the RBMSCs that
were cultured in the absence of Dex. These results corroborates
the histological and micro-CT findings which demonstrated
that new bone formation only occur in the explants seeded
with 1 × 106 RBMSCs exposed to Dex and Dex-loaded CMCht/
PAMAM dendrimer NPs. A significant increase (P b 0.001) in
the calcium deposited is observed when expanding the RBMSCs
with Dex-loaded CMCht/PAMAM dendrimer NPs ain compar-
ison with to explants seeded with 1 × 106 RBMSCs exposed to
Dex, which in its turn denoted the superior mineralization of the
newly formed bone. We advance a possible explanation for the
superior bone organization and mineralization observed in the
explants whose RBMSCs were cultured with Dex-loaded
CMCht/PAMAM dendrimer NPs. This can be due to the supply
of Dex for longer time and in a regimented manner, as Dex
possibly can be released from the NPs inside cells during in vivoimplantation time. However, further studies need to be carried out
to clarify this issue and to investigate the interaction of Dex with
the GC receptors and its translocation into the nucleus. The
biochemical data shows that the acellular approach, i.e., SPCL
scaffolds alone, does not induce in vivo de novo bone formation.
However, by seeding RBMSCs supplemented with Dex onto the
SPCL scaffolds, bone formation can be observed when cell
density was 1 × 106 cells per scaffold. The SPCL scaffolds proved
to be adequate for fundamental studies as it supported new bone
formation while allowing us to quantitatively assess new bone
formation in vivo, thus satisfying the requirements of a temporary
scaffold for the effective stem cells “tune-up” (Figure 5), and to
be used in basic studies.
In summary, the synthesized dendron like Dex-loaded
CMCht/PAMAM dendrimer NPs were found to possess a pH
and ionic-responsive nature. The NPs were able to be
internalized by cells and to promote the osteogenic differenti-
ation of RBMSCs in vitro. The present work demonstrated the
use of noncytotoxic NPs able to modulate the differentiation
pathway from the interior of stem cells, being able, in particular
to promote superior bone formation in vivo, when combining
such stem cell-based strategies and tissue engineering ap-
proaches. This work clearly evidences the advantage of using
intracellular nanocarrier tools for preprogramming the stem cells
ex vivo as these NPs show promise in the development of new
bone tissue.Appendix A. Supplementary data
Supplementary data to this article can be found online at
doi:10.1016/j.nano.2011.03.002.References
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